Medical Countermeasures: Long-Term Funding Could Spur More Development Work
Executive Summary
Chimerix CEO tells Congress allocating Project Bioshield a multi-year funding stream would provide more long-term certainty for countermeasure sponsors.
You may also be interested in...
Biodefense Bill Moving In Senate; Still Debate Over Best Approach For Flu
US Pandemic and All Hazards Preparedness Act appears on track for on-time reauthorization – but there may still be debate over whether and how to dedicate funding specifically for pandemic flu preparedness and stockpiling.
Drug Shortage Legislation Possible As US FDA Seeks New Powers To Prevent Problems
Commissioner Gottlieb proposes new authorities that could require manufacturers of certain drugs to establish risk mitigation plans to avert potential drug shortages.
Priority Review Voucher Crash: Spark's Sale To Jazz Lowest Price Since 2014
Only the first publicly disclosed sale of a priority review voucher was lower than what Jazz Pharmaceuticals paid Spark Therapeutics for its coupon.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: